An #AI algorithm is first proven by its robust training data set. Then, it is proven again by thousands of facilities worldwide who use it every day, repeatedly validating its effectiveness. #ProFoundAI is trusted daily at 1,500+ global facilities, where #radiologists augment their reviews on over 8M+ #mammograms annually, elevating peace of mind and patient care opportunities. Want to learn more about the ProFound Breast Health Suite or talk to one of our customers who is similar to you? Learn More: https://bit.ly/3RudgOb #BreastAI, #WhatsNextInAI, #RadiologyAI, #AI
iCAD
Hospitals and Health Care
Nashua, NH 12,147 followers
Creating a world where cancer can’t hide.
About us
At iCAD, we believe that is possible to create a world where cancer can't hide. Leveraging the power of artificial intellegence (AI), we empower healthcare providers to more accurately, reliably, and quickly detect disease and improve outcomes. The ProFound Breast Health Suite offers a comprehensive portfolio of clinically proven AI technologies for breast cancer detection, automated breast density assessment, and short-term personalized risk evaluation providing certainty and peace of mind - Optimizing every patient’s opportunity to live better, longer lives! To learn more, visit www.icadmed.com.
- Website
-
https://www.icadmed.com/
External link for iCAD
- Industry
- Hospitals and Health Care
- Company size
- 51-200 employees
- Headquarters
- Nashua, NH
- Type
- Public Company
- Founded
- 1984
- Specialties
- Computer Aided Detection, Breast Cancer, Healthcare, Cancer, Breast Density Assessment, Breast Tomosynthesis, Artificial Intelligence Software Solutions, AI, Deep Learning, Breast Cancer Detection Solutions, Technology, Women's Healthcare, Mammography, OEM, Partner, SaaS, Mammogram, Software Sales, Early Detection, Density Assessment, Risk Evalutation, and Heart Health
Locations
-
Primary
98 Spit Brook Road
Nashua, NH 03062, US
-
Employees at iCAD
-
Michelle Strong
COO at iCAD -- improving patient outcomes with ProFound AI breast cancer risk and detection solutions
-
Brian Testa
Global Chief People Officer / Board Member / Start-Up & Culture Enthusiast / Not Open to Franchise Opportunities
-
Michael Doyle
CEO, President and Board Member
-
Lisa Dundon
Updates
-
Joins us at #SIFEM 24# in Nantes, France June 13-15. We’re showcasing the newest features in #BreastAI that allows radiologists to find breast cancers at an earlier stage. Meet our team at booth 11 to view cases with and without to see how ProFound AI solutions can help you in your daily clinical practice in identifying small, critical lesions or validating normal cases faster. Join Us: https://bit.ly/4bE6htI #ProFoundAI, #iCAD, #BreastAI
-
[#SIIM24] We are looking forward to meeting up with our partners and customers at the Society for Imaging Informatics in Medicine (SIIM) annual meeting, June 27-29 in Maryland. #ProFoundAI works seamlessly with any platform and is currently in production with 50+ PACS to augment mammography insights and reading performance for a radiologist. Whether you’re considering adding #AI to your facility or looking to make an upgrade to your platform, stop by Booth #413 to talk with our technical product experts to ask all your #BreastAI questions. Schedule a Meeting: https://bit.ly/3KkWgG7 #BreastAI, #WhatsNextInAI, #Radiologists, #RadiologyAI
-
iCAD reposted this
-
[#BlogSeries] Radiologists are mammogram experts with valuable time and heavy workloads. #AI-powered mammography allows them to focus on complex cases and patient care, while efficiently handling routine screenings. This collaboration enhances performance, care quality, and reduces anxiety over missed diagnoses. Seamlessly integrated into workflows, #ProFoundAI is a trusted partner. What clinical and diagnostic improvements do you think #BreastAI can best enhance? Read More: https://bit.ly/3V07vIR #iCAD #BreastAI
-
Today, iCAD announced the company will present at the MedInvest Conferences MedTech, AI & Digital Healthcare Conference on June 11-12, 2024 in San Francisco, CA. Dana Brown, Chief Executive Officer and Eric Lonnqvist, Chief Financial Officer, of iCAD, Inc., will participate in one-on-one meetings with investors at the event. Investors interested in connecting with iCAD are requested to register at the link provided in the press release: https://bit.ly/3wK63lW
-
Some of #ProFoundAI’s most requested features are available to help #radiologists identify the small, hard-to-find cancers faster. From color-coded scoring to help triage cases and limited marks to focus on the most critical lesions based on level of suspicion, #radiologists and breast imaging centers are eager to upgrade today. Learn about the Improved Readability: https://bit.ly/3WXuCq4 #ProFoundAI, #iCAD, #WhatsNextinAI
-
Today we celebrate everyone who has conquered one of life's toughest battles - cancer. On #NationalCancerSurvivorsDay, we honor your strength, resilience and unwavering spirit. With over 4 million breast cancer survivors in the US, your journey is a testament to the power of hope, courage and the human spirit. We stand together in support, spreading awareness, and advocating for continued research to improve the lives of survivors and those still fighting. Your bravery inspires us all. Our focus remains on creating a world where cancer can’t hide. #BreastAI, #ProFoundAI, #iCAD
-
[#Webinar Replay] Hear from Dr. Nikki Gidwaney, Diagnostic Breast Fellowship Trained Radiologist at Stony Brook University Hospital, as she discusses how breast imaging centers and #radiologists are staying at the forefront with best-in-class #AI solutions. She will highlight her personal journey with #BreastAI solutions and the power of iCAD's newest algorithm in helping imaging centers meet key clinical, operational, quality, and financial business objectives. Replay: https://bit.ly/4dNtZW7 #ProFoundWebinar, #ProFoundAI, #WhatsNextinAI, #iCAD, #EarlyDetection
-
Women’s Health Month may be ending, but our focus stays firmly grounded in creating a world where cancer can’t hide. Early breast cancer risk assessment and vigilance is necessary for women of all ages. Regular AI-powered #mammograms are the best chance of early detection, when outcomes are best. Do you know the current screening recommendations for women at 25, 40, 75 and beyond? Learn More: https://bit.ly/4arHTKt #KnowYourRisk, #BreastAI, #ProFoundAI, #iCAD, #WomensHealthMonth
Affiliated pages
Similar pages
Browse jobs
Stock
ICAD
NASDAQ
20 minutes delay
$1.51
-0.03 (-1.948%)
- Open
- 1.6
- Low
- 1.51
- High
- 1.6
Data from Refinitiv
See more info on